Use of PROMOGRAN™ Matrix and PROMOGRAN PRISMA™ Matrix is beneficial in managing the underlying biochemistry of chronic wounds. Educational support should be provided to healthcare professionals before the introduction of these dressings and for their use to be monitored in practice and outcomes of care measured.
PROMOGRAN™ Matrix and PROMOGRAN PRISMA™ Matrix should be considered when no progression is seen after 4 weeks of delivering best practice care, in order to kick-start healing in chronic wounds.
The new proposed pathway for use in practice will help clinicians to identify a clear stop point of when these dressings should no longer be used, when to consider referral and when to re-assess and review the diagnosis, patient objectives and expectations.
